Clinical and Diagnostic Laboratory Immunology, September 1998, p. 725-731, Vol. 5, No. 5
1071-412X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Research Center in Oral
Biology,1
Dental Public Health
Sciences,2 and
Department of
Periodontics,
Received 24 February 1998/Returned for modification 5 May
1998/Accepted 22 June 1998
Evidence indicating that multiple serotypes of Bacteroides
forsythus participate in rapidly progressing periodontal
infections has not been reported previously. Our aim was to develop an
assay for detecting subsets of B. forsythus clinical
isolates which differ in serogroup membership and subsets of patients
with immunoglobulin G (IgG) responses which differ in serogroup
recognition. A checkerboard enzyme-linked immunosorbent assay (ELISA)
was used to assess variation in the IgG binding profiles of 22 clinical
isolates in sera from 28 patients with early-onset rapidly progressive
periodontitis. To accommodate the maximum number of isolates and sera
in a given assay run, a multiplate assay grid with standard 96-well
microtest plates was established. Single dilutions of individual sera
were placed in rows crossing columns of isolate-coated wells, and
antigen-specific IgG immobilized in the wells was measured as ELISA
absorbance. Pooled sera and isolates were assayed in parallel to serve
as negative controls for variation in IgG binding profiles. Correlation and hierarchical cluster analysis of the absorbance data matrix showed
that the isolates could be sorted into at least four clusters based on
variations in their IgG binding profiles across different sera.
Furthermore, at least two patient clusters were defined by variations
in their serum IgG antigen recognition profiles across different
isolates. We conclude that multiple serogroups of B. forsythus exist and that different serogroups are dominant in the
antibody response of different patients. The method applied here could
be used to serologically classify clinical isolates of other species
which evoke a serum antibody response in patients.
*
Corresponding author. Mailing address: Research Center
in Oral Biology, Box 357480, University of Washington, Seattle, WA 98195. Phone: 206-543-5599. Fax: 206-685-8024. E-mail:
rcobiol{at}u.washington.edu.
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. | Infect. Immun. |
|---|---|---|
| J. Clin. Microbiol. | J. Virol. | ALL ASM JOURNALS |